Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?-Reference-Cited by-同舟云学术

Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?

Published:2016-11-08 Issue:3 Volume:45 Page:646-659
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J. Magn. Reson. Imaging

Author:

Ba-Ssalamah Ahmed¹,Bastati Nina²,Wibmer Andreas¹,Fragner Romana¹,Hodge Jacqueline C.¹,Trauner Michael²,Herold Christian J.¹,Bashir Mustafa R.³⁴,Van Beers Bernard E.⁵

Affiliation:

1. Department of Biomedical Imaging and Image-guided Therapy; Medical University Vienna; Austria

2. Division of Gastroenterology and Hepatology, Department of Internal Medicine III; Medical University of Vienna, General Hospital of Vienna (AKH); Austria

3. Department of Radiology and Center for Advanced Magnetic Resonance Development; Duke University Medical Center; Durham North Carolina USA

4. Center for Advanced Magnetic Resonance Development; Duke University Medical Center; Durham North Carolina USA

5. Laboratory of Imaging Biomarkers, UMR 1149, INSERM - University Paris Diderot and Department of Radiology; University Hospital Paris Nord - Beaujon; France

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging

Reference109 articles.

1. New imaging techniques for liver diseases;Beers;J Hepatol,2015

2. Liver biopsy;Bravo;N Engl J Med,2001

3. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF);Cadranel;Hepatology,2000

4. Liver biopsy: past, present and future;Ravindran;Br J Hosp Med (Lond),2016

5. Serum markers detect the presence of liver fibrosis: a cohort study;Rosenberg;Gastroenterology,2004

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Native and Gd-EOB-DTPA-Enhanced T1 mapping for Assessment of Liver Fibrosis in NAFLD: Comparative Analysis of Modified Look-Locker Inversion Recovery and Water-specific T1 mapping;Academic Radiology;2024-07

2. This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol;Seminars in Liver Disease;2024-05

3. Comparison of the efficacy of the gadoxetic acid MRI-derived relative enhancement index (REI) and functional liver imaging score (FLIS) in predicting liver function: validation with Albumin-Bilirubin (ALBI) grade;Abdominal Radiology;2024-04-23

4. Non-contrast T1ρ dispersion versus Gd-EOB-DTPA-enhanced T1mapping for the risk stratification of non-alcoholic fatty liver disease in rabbit models;Magnetic Resonance Imaging;2024-04

5. Evaluation and Prediction of Post-Hepatectomy Liver Failure Using Imaging Techniques: Value of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging;Korean Journal of Radiology;2024